[{"address1": "Uppsalalaan 17", "address2": "3rd & 4th floor", "city": "Utrecht", "zip": "3584 CT", "country": "Netherlands", "phone": "31 30 253 8800", "website": "https://www.merus.nl", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer and castration-resistant prostate cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; collaboration with Incyte Corporation for the development of MCLA-145; and collaboration with Gilead Sciences, Inc. to discover novel antibody-based trispecific T-cell engagers. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.", "fullTimeEmployees": 260, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sven Ante Lundberg M.D.", "age": 61, "title": "CEO, President & Executive Director", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1114527, "exercisedValue": 0, "unexercisedValue": 10252539}, {"maxAge": 1, "name": "Mr. Gregory D. Perry", "age": 64, "title": "Chief Financial Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 419102, "exercisedValue": 0, "unexercisedValue": 801494}, {"maxAge": 1, "name": "Mr. Peter B. Silverman J.D.", "age": 46, "title": "EVP, Company Secretary, COO, General Counsel, Chief Intellectual Property Officer & Head of US Legal", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 781842, "exercisedValue": 565022, "unexercisedValue": 1331558}, {"maxAge": 1, "name": "Dr. Hennie  Hoogenboom", "title": "Co-Founder and Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Harry  Shuman", "title": "Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cornelis Adriaan de Kruif Ph.D.", "age": 59, "title": "CTO & Executive VP", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 349379, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cecilia Anna Wilhelmina Geuijen Ph.D.", "title": "Chief Scientific Officer & Senior VP", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen  Farren", "title": "IR & Corporate Communications Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Audrey  Bergan", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shannon  Campbell", "age": 58, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 46.1, "open": 45.82, "dayLow": 45.335, "dayHigh": 47.205, "regularMarketPreviousClose": 46.1, "regularMarketOpen": 45.82, "regularMarketDayLow": 45.335, "regularMarketDayHigh": 47.205, "payoutRatio": 0.0, "beta": 1.153, "forwardPE": -11.81282, "volume": 638604, "regularMarketVolume": 638604, "averageVolume": 631308, "averageVolume10days": 758390, "averageDailyVolume10Day": 758390, "bid": 33.39, "ask": 58.17, "bidSize": 2, "askSize": 2, "marketCap": 3182999040, "fiftyTwoWeekLow": 37.77, "fiftyTwoWeekHigh": 61.61, "priceToSalesTrailing12Months": 88.091194, "fiftyDayAverage": 42.3989, "twoHundredDayAverage": 48.947674, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2655883008, "profitMargins": 0.0, "floatShares": 59197405, "sharesOutstanding": 69090496, "sharesShort": 6635045, "sharesShortPriorMonth": 7999941, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0964, "heldPercentInsiders": 0.020469999, "heldPercentInstitutions": 1.06562, "shortRatio": 13.37, "shortPercentOfFloat": 0.09689999, "impliedSharesOutstanding": 69090496, "bookValue": 9.414, "priceToBook": 4.8937755, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -215326000, "trailingEps": -3.35, "forwardEps": -3.9, "enterpriseToRevenue": 73.503, "enterpriseToEbitda": -9.851, "52WeekChange": -0.033948004, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 46.07, "targetHighPrice": 109.0, "targetLowPrice": 67.0, "targetMeanPrice": 86.5625, "targetMedianPrice": 88.0, "recommendationMean": 1.27778, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 16, "totalCash": 537027008, "totalCashPerShare": 7.773, "ebitda": -269596000, "totalDebt": 9912000, "quickRatio": 6.221, "currentRatio": 6.535, "totalRevenue": 36133000, "debtToEquity": 1.53, "revenuePerShare": 0.563, "returnOnAssets": -0.27466, "returnOnEquity": -0.42882, "grossProfits": 13424000, "freeCashflow": -123216872, "operatingCashflow": -185835008, "revenueGrowth": 0.022, "grossMargins": 0.37152, "ebitdaMargins": 0.0, "operatingMargins": -9.69934, "financialCurrency": "USD", "symbol": "MRUS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "longName": "Merus N.V.", "regularMarketChangePercent": -0.06507328, "regularMarketPrice": 46.07, "messageBoardId": "finmb_24929296", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Merus N.V.", "corporateActions": [], "postMarketTime": 1741386188, "regularMarketTime": 1741381201, "exchange": "NGM", "epsTrailingTwelveMonths": -3.35, "epsForward": -3.9, "epsCurrentYear": -3.97321, "priceEpsCurrentYear": -11.595159, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1463664600000, "postMarketChangePercent": 0.282182, "postMarketPrice": 46.2, "postMarketChange": 0.130001, "regularMarketChange": -0.02999878, "regularMarketDayRange": "45.335 - 47.205", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 631308, "fiftyTwoWeekLowChange": 8.299999, "fiftyTwoWeekLowChangePercent": 0.2197511, "fiftyTwoWeekRange": "37.77 - 61.61", "fiftyTwoWeekHighChange": -15.540001, "fiftyTwoWeekHighChangePercent": -0.2522318, "fiftyTwoWeekChangePercent": -3.3948004, "earningsTimestamp": 1740690640, "earningsTimestampStart": 1746529140, "earningsTimestampEnd": 1747051200, "isEarningsDateEstimate": true, "fiftyDayAverageChange": 3.6711006, "fiftyDayAverageChangePercent": 0.08658481, "twoHundredDayAverageChange": -2.877674, "twoHundredDayAverageChangePercent": -0.058790825, "displayName": "Merus", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]